Skip to content

DexCom DXCM Cash ratio

Other financials

Income statement

See full
Revenue$1.2B+15.0%
Gross profit$750.3M+27.4%
Operating income$255.3M+91.0%
Net income$199.5M+89.3%
EPS (diluted)$0.51+88.9%

Balance sheet

See full
Cash & equivalents$1.1B+23.4%
Total debt$143.0M+2.2%
Total equity$3.0B+30.5%
Total assets$6.6B-1.8%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Market cap$27.49B-9.7%
Enterprise value$26.51B-10.8%
P/E29.5×-27.4×
P/S5.7×-1.6×

Profitability

See full
Gross margin61.5%+2.1pp
Operating margin21.4%+6.2pp
Net margin19.3%+6.4pp

Returns & leverage

See full
Return on equity35.6%+11.9pp
Debt / equity0.0×
Current ratio1.9×+0.4×

Where this comes from

Calculated from DexCom’s reported figures.

Based on the most recent quarter.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's cash ratio.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's cash ratio?
DexCom (DXCM) reported cash ratio of 0.5× in Q1 2026.
How has DexCom's cash ratio changed year-over-year?
DexCom's cash ratio increased by 68.6% year-over-year, from 0.3× to 0.5×.
What is the long-term trend for DexCom's cash ratio?
Over 4 years (2021 to 2025), DexCom's cash ratio has grown at a -29.4% compound annual growth rate (CAGR), from 6.6× to 1.6×.
What does cash ratio mean?
How much of its short-term bills the company could pay with cash on hand right now.
How do you interpret cash ratio?
A buffer against stress, but persistently high cash ratios can indicate under-deployed capital. Interpret alongside the company's capital-allocation strategy.
How does cash ratio compare across companies?
Varies widely by business model and treasury policy; best read against the company's own history.